New Diet Pill Awaits FDA Approval

June 10, 2014 12:40 PM

5 0

New Diet Pill Awaits FDA Approval

A new pill might soon be available for obese people who are trying to lose weight. The drug in question is Orexigen Therapeutics' Contrave, currently known as NB32. The U.S. Food and Drug Administration (FDA) is expected to make a decision by this Wednesday and according to analysts, that decision will go in favor of the drug.

The FDA had previously rejected Contrave in January 2011. In order to resubmit an application for FDA review and approval, Orexigen conducted a multiyear study to find evidence that Contrave is safe for patients' cardiovascular health. So far, the ongoing study that involves 8,900 patients has found...

Read more

To category page

Loading...